PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-10-23

Date Title Company
23-Oct-2024 Capital Markets Event 2024: Lundbeck to showcase progress on Focused Innovator Strategy driving sustainable long-term growth H. Lundbeck A/S
23-Oct-2024 DARZALEX® (daratumumab)-SC based quadruplet regimen approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible Janssen-Cilag International NV
23-Oct-2024 Senzime secures first European hospital order for its new next-generation TetraGraph system Senzime
23-Oct-2024 Biocartis announces six Idylla™ abstracts to be presented at AMP 2024 Annual Meeting Biocartis NV
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics
23-Oct-2024 Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset Angelini Pharma
23-Oct-2024 LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR DONANEMAB (KISUNLA ®▼) FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER’S DISEASE IN ADULT PATIENTS WHO ARE APOLIPOPROTEIN E ε4 HETEROZYGOTES OR NON-CARRIERS Eli Lilly and Company Limited
23-Oct-2024 OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain OKYO Pharma Limited
23-Oct-2024 HealthJoy and Mark Cuban Cost Plus Drug Company Team Up to Improve Access to Affordable Prescription Drugs AccessWire
23-Oct-2024 ZetrOZ Systems and TOBI Network Announce Webinar on Sustained Acoustic Medicine for Discogenic Back Pain AccessWire
23-Oct-2024 Kerr Dental Releases ZenFlex CM Rotary File for Predictable and Effective Endodontic Procedures AccessWire
23-Oct-2024 Global Large Granular Lymphocytic Leukemia (LGLL) Therapeutics Market Expected to Reach USD 12,700 Million by 2033 at a 16.03% of CAGR, Fuelled by Significant Growth in Treatment Options MARKITWIRED
23-Oct-2024 Global Vaginal and Vulval Inflammatory Diseases Treatment Market Projected to Reach USD 5.21 Billion by 2033 at a 5.8% of CAGR, Driven by Steady Growth and Increased Awareness MARKITWIRED
23-Oct-2024 Xcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare Campaign AccessWire
23-Oct-2024 Global Progressive Fibrosing Interstitial Lung Disease Market Projected to Reach USD 8654.1 Million by 2033 at a 6.2% of CAGR MARKITWIRED
23-Oct-2024 TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC AccessWire
23-Oct-2024 Global Transfusion Dependent Thalassaemia Management Market Expected to Reach USD 17.91 Million by 2033 at a 6% of CAGR, Fueled by Rising Awareness and Advancements in Treatment MARKITWIRED
23-Oct-2024 Global Ringworm Treatment Market Expected to Reach USD 13.91 Billion in 2033 at a 5.2% of CAGR, Driven by High Prevalence of Skin Diseases MARKITWIRED
23-Oct-2024 Global PPG Biosensors Market Set to Reach USD 1.9 Billion by 2033 at a 15.2% of CAGR, Driven by Heart Rate Monitoring Applications MARKITWIRED
23-Oct-2024 Global Hematopoietic Stem Cell Transplantation Market to Reach USD 15 Billion by 2033 at a 8% of CAGR, Driven by Rising Leukemia and Lymphoma Cases MARKITWIRED